Cardiol Therapeutics Inc.
CRDL
$1.15
$0.00990.87%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 13.34M | 16.21M | 21.25M | 11.76M | 17.55M |
Total Receivables | 205.20K | 241.20K | 251.30K | 197.40K | 177.10K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 952.60K | 1.14M | 504.90K | 836.40K | 1.18M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 14.50M | 17.58M | 22.01M | 12.79M | 18.91M |
|
|||||
Total Current Assets | 14.50M | 17.58M | 22.01M | 12.79M | 18.91M |
Net Property, Plant & Equipment | 119.90K | 127.00K | 135.90K | 176.10K | 192.20K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | 0.00 | 0.00 | 122.80K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 14.62M | 17.71M | 22.15M | 12.97M | 19.23M |
|
|||||
Total Accounts Payable | 5.86M | 5.37M | 4.85M | 5.12M | 6.89M |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 26.10K | 23.80K | 22.90K | 23.50K | 15.90K |
Total Finance Division Other Current Liabilities | -- | -- | -- | 2.70K | 990.60K |
Total Other Current Liabilities | -- | -- | -- | 2.70K | 990.60K |
Total Current Liabilities | 5.88M | 5.39M | 4.87M | 5.15M | 7.90M |
|
|||||
Total Current Liabilities | 5.88M | 5.39M | 4.87M | 5.15M | 7.90M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 78.50K | 81.00K | 87.20K | 99.30K | 104.20K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 5.96M | 5.47M | 4.96M | 5.25M | 8.00M |
|
|||||
Common Stock & APIC | 152.29M | 142.71M | 141.77M | 134.82M | 126.92M |
Retained Earnings | -143.63M | -130.48M | -124.58M | -127.10M | -115.70M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 8.66M | 12.24M | 17.19M | 7.72M | 11.22M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 8.66M | 12.24M | 17.19M | 7.72M | 11.22M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 8.66M | 12.24M | 17.19M | 7.72M | 11.22M |
|